Back to Search
ROBERT ENELOW, M.D.
M.D.
Internal Medicine Physician
NPI: 1336151349Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
0101042350(VA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
TULANE UNIVERSITY SCHOOL OF MEDICINE
Class of 1985
Research & Publications (20)
Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice.
PMID 18654661·J Clin Invest·2008
7-preclinical
Cutting edge: engagement of NKG2A on CD8+ effector T cells limits immunopathology in influenza pneumonia.
PMID 18096998·J Immunol·2008
7-preclinical
Phenotypic alterations in type II alveolar epithelial cells in CD4+ T cell mediated lung inflammation.
PMID 17610738·Respir Res·2007
4-observational
Cellular immunity and lung injury in respiratory virus infection.
PMID 16817757·Viral Immunol·2006
6-review
Lung epithelial NF-kappaB and Stat1 signaling in response to CD8+ T cell antigen recognition.
PMID 16689660·J Interferon Cytokine Res·2006
7-preclinical
Regulation of gene expression in RAW 264.7 macrophage cell line by interferon-gamma.
PMID 16516165·Biochem Biophys Res Commun·2006
7-preclinical
Requirement for tumor necrosis factor-receptor 2 in alveolar chemokine expression depends upon the form of the ligand.
PMID 16081883·Am J Respir Cell Mol Biol·2005
7-preclinical
Differential effects of lipoprotein lipase on tumor necrosis factor-alpha and interferon-gamma-mediated gene expression in human endothelial cells.
PMID 15994321·J Biol Chem·2005
8-other
Stat1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of Stat3 in mouse embryonic fibroblasts.
PMID 15649407·Biochem Biophys Res Commun·2005
4-observational
CD4 T Lymphocyte-mediated lung disease: steady state between pathological and tolerogenic immune reactions.
PMID 15306530·Am J Respir Crit Care Med·2004
7-preclinical
Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells.
PMID 15240656·J Immunol·2004
7-preclinical
Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis.
PMID 15044205·Am J Respir Crit Care Med·2004
3-trial
Inhibition of effector T lymphocytes mediated through antagonism of IL-4.
PMID 15007362·J Allergy Clin Immunol·2004
8-other
Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury.
PMID 14762366·J Thorac Cardiovasc Surg·2004
4-observational
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.
PMID 11748284·J Exp Med·2001
7-preclinical
Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation.
PMID 11588015·Am J Respir Cell Mol Biol·2001
7-preclinical
Alveolar epithelial cell chemokine expression induced by specific antiviral CD8+ T-cell recognition plays a critical role in the perpetuation of experimental interstitial pneumonia.
PMID 11451886·Chest·2001
7-preclinical
Laparotomy potentiates cytokine release and impairs pulmonary function after hemorrhage and resuscitation in mice.
PMID 11242288·J Trauma·2001
7-preclinical
Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition.
PMID 10995793·J Clin Invest·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1140 19TH ST NW, SUITE 500
WASHINGTON, DC 20036 - Phone
- (202) 728-9630
Quick Facts
- NPI
- 1336151349
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile